PHAT · Phathom Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Basta Steven L President and CEO | ▼ Sell | Tax Withholding | 373,315 Shares held | 2/10/2026 | View profile |
| Terrie Curran President and Chief Executive | ▼ Sell | Open Market | 360,465 Shares held | 1/21/2025 | View profile |
| Nabulsi Azmi Chief Operating Officer | ▲ Buy | Grant | 312,590 Shares held | 2/27/2025 | View profile |
| Narula Sanjeev Chief Financial & Bus. Officer | ▼ Sell | Tax Withholding | 214,718 Shares held | 10/6/2026 | View profile |
| Parikh Asit Director | ▼ Sell | Gift | 148,500 Shares held | 5/22/2026 | View profile |
| KARBE FRANK Director | ▲ Buy | Grant | 91,622 Shares held | 5/19/2026 | View profile |
| Henderson Molly CFO and CBO | ▼ Sell | Open Market | 89,868 Shares held | 4/7/2025 | View profile |
| Cook Anne Marie Chief Legal Off. & Corp. Sec. | ▼ Sell | Tax Withholding | 88,660 Shares held | 2/10/2026 | View profile |
| James N. Topper Director | ▲ Buy | Grant | 66,718 Shares held | 5/19/2026 | View profile |
| COLA MICHAEL F Director | ▲ Buy | Grant | 63,920 Shares held | 5/19/2026 | View profile |
| Breedlove Robert Charles Principal Accounting Officer | ▼ Sell | Tax Withholding | 59,465 Shares held | 9/3/2026 | View profile |
| FIELDS HEIDI Director | ▲ Buy | Grant | 54,122 Shares held | 5/19/2026 | View profile |
| Stenhouse Mark Director | ▲ Buy | Grant | 54,122 Shares held | 5/19/2026 | View profile |
| Schroeder Theodore R | ▲ Buy | Grant | 45,122 Shares held | 5/19/2026 | View profile |
| Socks David A Director | ▲ Buy | Grant | 19,500 Shares held | 5/23/2024 | View profile |
| Guzzo Anthony J. VP, Chief Accounting Officer | ▲ Buy | Grant | 8,399 Shares held | 1/19/2022 | View profile |
Transaction History
| Narula Sanjeev | ▼ Sell | Tax Withholding | 13,485 | $91K | 10/6/2026 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 460 | $4K | 9/3/2026 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 1,555 | $17K | 7/14/2026 |
| Parikh Asit | ▼ Sell | Gift | 28,000 | $0 | 5/22/2026 |
| Parikh Asit | ▼ Sell | Gift | 28,000 | $0 | 5/22/2026 |
| Parikh Asit | ▲ Buy | Option Exercise | 17,500 | $87K | 5/20/2026 |
| Parikh Asit | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| James N. Topper | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| Stenhouse Mark | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| FIELDS HEIDI | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| COLA MICHAEL F | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| KARBE FRANK | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| Schroeder Theodore R | ▲ Buy | Grant | 24,122 | $0 | 5/19/2026 |
| Parikh Asit | ▼ Sell | Gift | 40,000 | $0 | 3/10/2026 |
| Parikh Asit | ▼ Sell | Gift | 40,000 | $0 | 3/10/2026 |
| Breedlove Robert Charles | ▲ Buy | Grant | 13,000 | $0 | 2/27/2026 |
| Breedlove Robert Charles | ▲ Buy | Grant | 2,790 | $0 | 2/27/2026 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 964 | $12K | 2/27/2026 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 414 | $5K | 2/27/2026 |
| Cook Anne Marie | ▲ Buy | Grant | 3,461 | $0 | 2/10/2026 |
| Cook Anne Marie | ▼ Sell | Tax Withholding | 1,535 | $20K | 2/10/2026 |
| Basta Steven L | ▲ Buy | Grant | 12,362 | $0 | 2/10/2026 |
| Basta Steven L | ▼ Sell | Tax Withholding | 6,277 | $80K | 2/10/2026 |
| Parikh Asit | ▼ Sell | Gift | 80,500 | $0 | 1/23/2026 |
| Parikh Asit | ▼ Sell | Gift | 80,500 | $0 | 1/23/2026 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 776 | $11K | 1/21/2026 |
| Parikh Asit | ▲ Buy | Option Exercise | 8,750 | $90K | 1/13/2026 |
| Basta Steven L | ▲ Buy | Grant | 251,034 | $0 | 1/2/2026 |
| Cook Anne Marie | ▲ Buy | Grant | 75,345 | $0 | 1/2/2026 |
| Narula Sanjeev | ▲ Buy | Grant | 82,715 | $0 | 1/2/2026 |
| Parikh Asit | ▲ Buy | Option Exercise | 8,750 | $90K | 12/19/2025 |
| Breedlove Robert Charles | ▼ Sell | Tax Withholding | 230 | $4K | 12/18/2025 |
| Cook Anne Marie | ▲ Buy | Grant | 17,370 | $0 | 12/17/2025 |
| Cook Anne Marie | ▼ Sell | Tax Withholding | 7,703 | $118K | 12/17/2025 |
| Basta Steven L | ▲ Buy | Grant | 62,038 | $0 | 12/17/2025 |
| Basta Steven L | ▼ Sell | Tax Withholding | 31,502 | $484K | 12/17/2025 |
| Basta Steven L | ▲ Buy | Option Exercise | 90,000 | $0 | 11/28/2025 |
| Basta Steven L | ▼ Sell | Tax Withholding | 48,375 | $756K | 11/28/2025 |
| Breedlove Robert Charles | ▼ Sell | Open Market | 524 | $7K | 11/3/2025 |
| Basta Steven L | ▲ Buy | Option Exercise | 90,000 | $0 | 9/25/2025 |
| Basta Steven L | ▼ Sell | Tax Withholding | 48,375 | $564K | 9/25/2025 |
| Breedlove Robert Charles | ▼ Sell | Open Market | 461 | $6K | 9/5/2025 |
| Breedlove Robert Charles | ▼ Sell | Open Market | 1,692 | $14K | 7/16/2025 |
| COLA MICHAEL F | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| James N. Topper | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| FIELDS HEIDI | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| Stenhouse Mark | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| Parikh Asit | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| KARBE FRANK | ▲ Buy | Grant | 10,500 | $0 | 6/3/2025 |
| James N. Topper | ▲ Buy | Open Market | 3,780 | $15K | 5/21/2025 |
| James N. Topper | ▲ Buy | Open Market | 6,300 | $21K | 5/14/2025 |
| James N. Topper | ▲ Buy | Open Market | 1,120 | $4K | 5/13/2025 |
| James N. Topper | ▲ Buy | Open Market | 12,601 | $38K | 5/12/2025 |
| James N. Topper | ▲ Buy | Open Market | 33,376 | $107K | 5/9/2025 |
| James N. Topper | ▲ Buy | Open Market | 2,226 | $8K | 5/9/2025 |
| Parikh Asit | ▲ Buy | Open Market | 5,000 | $12K | 5/7/2025 |
| Parikh Asit | ▲ Buy | Open Market | 5,000 | $13K | 5/6/2025 |
| Schroeder Theodore R | ▲ Buy | Grant | 21,000 | $0 | 4/16/2025 |
| Henderson Molly | ▼ Sell | Open Market | 3,678 | $17K | 4/7/2025 |
| Parikh Asit | ▲ Buy | Open Market | 10,000 | $44K | 3/13/2025 |
| Henderson Molly | ▲ Buy | Grant | 72,000 | $0 | 2/27/2025 |
| Nabulsi Azmi | ▲ Buy | Grant | 79,200 | $0 | 2/27/2025 |
| Henderson Molly | ▼ Sell | Open Market | 6,583 | $43K | 1/21/2025 |
| Nabulsi Azmi | ▼ Sell | Open Market | 7,886 | $52K | 1/21/2025 |
| Terrie Curran | ▼ Sell | Open Market | 19,109 | $126K | 1/21/2025 |
| Nabulsi Azmi | ▼ Sell | Open Market | 1,118 | $9K | 12/19/2024 |
| Henderson Molly | ▼ Sell | Open Market | 1,291 | $10K | 12/19/2024 |
| KARBE FRANK | ▲ Buy | Open Market | 12,500 | $99K | 12/13/2024 |
| Parikh Asit | ▲ Buy | Open Market | 10,000 | $81K | 12/13/2024 |
| Parikh Asit | ▲ Buy | Option Exercise | 7,500 | $88K | 9/10/2024 |
| Nabulsi Azmi | ▼ Sell | Open Market | 10,901 | $128K | 7/15/2024 |
| Henderson Molly | ▼ Sell | Open Market | 4,325 | $51K | 7/15/2024 |
| Terrie Curran | ▼ Sell | Open Market | 33,848 | $397K | 7/15/2024 |
| Henderson Molly | ▲ Buy | Grant | 7,500 | $0 | 5/31/2024 |
| Nabulsi Azmi | ▲ Buy | Grant | 7,500 | $0 | 5/31/2024 |
| KARBE FRANK | ▲ Buy | Grant | 25,000 | $254K | 5/29/2024 |
| James N. Topper | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| Parikh Asit | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| FIELDS HEIDI | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| Stenhouse Mark | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| Socks David A | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| COLA MICHAEL F | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| KARBE FRANK | ▲ Buy | Grant | 10,500 | $0 | 5/23/2024 |
| Henderson Molly | ▼ Sell | Open Market | 3,435 | $38K | 4/8/2024 |
| Terrie Curran | ▼ Sell | Open Market | 16,851 | $154K | 3/22/2024 |
| Henderson Molly | ▼ Sell | Open Market | 6,307 | $49K | 1/19/2024 |
| Henderson Molly | ▼ Sell | Open Market | 2,127 | $15K | 11/20/2023 |
| Parikh Asit | ▲ Buy | Open Market | 2,500 | $20K | 11/8/2023 |
| Parikh Asit | ▲ Buy | Open Market | 4,000 | $31K | 11/7/2023 |
| Parikh Asit | ▲ Buy | Open Market | 1,000 | $8K | 11/6/2023 |
| Henderson Molly | ▲ Buy | Grant | 22,500 | $0 | 11/1/2023 |
| Henderson Molly | ▼ Sell | Open Market | 811 | $6K | 11/1/2023 |
| Henderson Molly | ▼ Sell | Open Market | 11,681 | $105K | 11/1/2023 |
| Nabulsi Azmi | ▲ Buy | Grant | 32,500 | $0 | 11/1/2023 |
| Terrie Curran | ▲ Buy | Grant | 37,500 | $0 | 11/1/2023 |
| Henderson Molly | ▲ Buy | Grant | 25,000 | $25K | 7/14/2023 |
| Nabulsi Azmi | ▲ Buy | Grant | 110,000 | — | 7/14/2023 |
| Terrie Curran | ▲ Buy | Grant | 200,000 | — | 7/14/2023 |
| Parikh Asit | ▲ Buy | Grant | 15,000 | $111K | 6/2/2023 |
| Henderson Molly | ▼ Sell | Open Market | 1,960 | $22K | 6/2/2023 |
| James N. Topper | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| Stenhouse Mark | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| Socks David A | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| Parikh Asit | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| FIELDS HEIDI | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| KARBE FRANK | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| COLA MICHAEL F | ▲ Buy | Grant | 9,000 | $0 | 5/25/2023 |
| Henderson Molly | ▼ Sell | Open Market | 2,110 | $27K | 5/22/2023 |
| Nabulsi Azmi | ▲ Buy | Open Market | 10,000 | $83K | 4/11/2023 |
| Parikh Asit | ▲ Buy | Open Market | 1,000 | $8K | 4/10/2023 |
| Terrie Curran | ▲ Buy | Open Market | 12,919 | $101K | 4/6/2023 |
| Henderson Molly | ▼ Sell | Open Market | 3,439 | $25K | 4/6/2023 |
| Henderson Molly | ▼ Sell | Open Market | 2,032 | $17K | 3/1/2023 |
| Terrie Curran | ▼ Sell | Open Market | 1,436 | $12K | 3/1/2023 |
| Parikh Asit | ▲ Buy | Open Market | 5,000 | $39K | 2/13/2023 |
| Terrie Curran | ▼ Sell | Open Market | 5,821 | $48K | 1/20/2023 |
| Terrie Curran | ▲ Buy | Grant | 97,500 | $0 | 1/19/2023 |
| Henderson Molly | ▲ Buy | Grant | 33,000 | $0 | 1/19/2023 |
| Nabulsi Azmi | ▲ Buy | Grant | 45,000 | $0 | 1/19/2023 |
| Parikh Asit | ▲ Buy | Open Market | 5,000 | $35K | 1/12/2023 |
| Henderson Molly | ▼ Sell | Open Market | 2,159 | $21K | 11/21/2022 |
| Terrie Curran | ▼ Sell | Open Market | 1,526 | $15K | 11/21/2022 |
| Terrie Curran | ▲ Buy | Grant | 7,500 | $0 | 9/1/2022 |
| Nabulsi Azmi | ▲ Buy | Grant | 7,500 | $0 | 9/1/2022 |
| Henderson Molly | ▲ Buy | Grant | 7,500 | $0 | 9/1/2022 |
| Nabulsi Azmi | ▲ Buy | Grant | 12,000 | $0 | 5/19/2022 |
| Henderson Molly | ▲ Buy | Grant | 12,000 | $0 | 5/19/2022 |
| Terrie Curran | ▲ Buy | Grant | 12,000 | $0 | 5/19/2022 |
| Nabulsi Azmi | ▲ Buy | Open Market | 20,000 | $163K | 5/16/2022 |
| Terrie Curran | ▲ Buy | Open Market | 20,500 | $152K | 5/13/2022 |
| Henderson Molly | ▲ Buy | Open Market | 6,000 | — | 5/13/2022 |
| Parikh Asit | ▲ Buy | Open Market | 12,500 | $100K | 5/12/2022 |
| Henderson Molly | ▲ Buy | Grant | 20,000 | $0 | 4/5/2022 |
| Guzzo Anthony J. | ▲ Buy | Grant | 6,000 | $0 | 1/19/2022 |
| Terrie Curran | ▲ Buy | Grant | 41,250 | $0 | 1/19/2022 |
| Nabulsi Azmi | ▲ Buy | Grant | 19,500 | $0 | 1/19/2022 |
| Socks David A | ▼ Sell | Open Market | 2,529 | $81K | 10/8/2021 |
| Socks David A | ▼ Sell | Open Market | 15,471 | $505K | 10/7/2021 |
| Socks David A | ▼ Sell | Open Market | 4,100 | $131K | 9/22/2021 |
| Socks David A | ▼ Sell | Open Market | 13,576 | $445K | 9/21/2021 |
| Socks David A | ▼ Sell | Open Market | 324 | $11K | 9/21/2021 |
| COLA MICHAEL F | ▲ Buy | Open Market | 9,798 | $186K | 10/29/2019 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
PHAT launches Phase 3 study for VOQUEZNA in GERD
Phathom Pharmaceuticals has begun a Phase 3 trial of VOQUEZNA, a drug aimed at treating non‑erosive gastro‑esophageal reflux disease on an as‑needed basis. The study is a critical step toward regulatory approval and could expand the company’s product portfolio. The move follows earlier development phases and may influence investor perception of the company’s growth prospects.
PHAT launches Phase 3 study for VOQUEZNA in GERD. Phathom Pharmaceuticals has begun a Phase 3 trial of VOQUEZNA, a drug aimed at treating non‑erosive gastro‑esophageal reflux disease on an as‑needed basis. The study is a critical step toward regulatory approval and could expand the company’s product portfolio. The move follows earlier development phases and may influence investor perception of the company’s growth prospects.